DK0552631T3 - Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider - Google Patents

Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider

Info

Publication number
DK0552631T3
DK0552631T3 DK93100273.7T DK93100273T DK0552631T3 DK 0552631 T3 DK0552631 T3 DK 0552631T3 DK 93100273 T DK93100273 T DK 93100273T DK 0552631 T3 DK0552631 T3 DK 0552631T3
Authority
DK
Denmark
Prior art keywords
alpha
aryl
hydroxy
propionsyreamider
imidazolinyl
Prior art date
Application number
DK93100273.7T
Other languages
Danish (da)
English (en)
Inventor
Wilfried Dr Draber
Hilmar Dr Bischoff
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0552631T3 publication Critical patent/DK0552631T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK93100273.7T 1992-01-23 1993-01-11 Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider DK0552631T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4201709A DE4201709A1 (de) 1992-01-23 1992-01-23 (alpha)-aryl-(alpha)-hydroxy-ss-imidazolinyl-propionsaeureamide

Publications (1)

Publication Number Publication Date
DK0552631T3 true DK0552631T3 (da) 1998-05-11

Family

ID=6450062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93100273.7T DK0552631T3 (da) 1992-01-23 1993-01-11 Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider

Country Status (22)

Country Link
US (1) US5334610A (enExample)
EP (1) EP0552631B1 (enExample)
JP (1) JPH05286942A (enExample)
KR (1) KR930016401A (enExample)
CN (1) CN1075714A (enExample)
AT (1) ATE158576T1 (enExample)
AU (1) AU650807B2 (enExample)
CA (1) CA2087650A1 (enExample)
CZ (1) CZ282024B6 (enExample)
DE (2) DE4201709A1 (enExample)
DK (1) DK0552631T3 (enExample)
ES (1) ES2107562T3 (enExample)
GR (1) GR3025179T3 (enExample)
HU (1) HUT63394A (enExample)
IL (1) IL104444A (enExample)
MX (1) MX9300136A (enExample)
MY (1) MY108826A (enExample)
NZ (1) NZ245726A (enExample)
PL (1) PL172005B1 (enExample)
SK (1) SK372292A3 (enExample)
TW (1) TW232011B (enExample)
ZA (1) ZA93477B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403818B1 (en) 2000-02-28 2002-06-11 Eisai Co., Ltd. Process for producing α-hydroxy-carbonyl compound
JP2005523314A (ja) 2002-04-18 2005-08-04 ユニバーシティ オブ バージニア パテント ファウンデーション 新規ナトリウムチャンネル遮断化合物
JP2006509015A (ja) * 2002-12-04 2006-03-16 メルク エンド カムパニー インコーポレーテッド スピロ環尿素、そのような化合物を含有する組成物、及び使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2623377A1 (de) * 1975-05-30 1976-12-09 Scherico Ltd 2-imidazoline und ihre anwendung in pharmazeutischen zubereitungen sowie verfahren zu ihrer herstellung
DE2614240C3 (de) * 1976-04-02 1980-03-06 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Acylcyaniden
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
US4136188A (en) * 1976-06-25 1979-01-23 Daiichi Seiyaku Co., Ltd. Treatment of diabetes with 2-substituted-1,3-diazacyclic compounds
US4226876A (en) * 1976-12-20 1980-10-07 Burroughs Wellcome Co. Arthropodicidal imidazoline derivatives
DK344489D0 (da) * 1989-07-12 1989-07-12 Novo Nordisk As Substituerede 2-imidazoliner og fremstilling og anvendelse deraf

Also Published As

Publication number Publication date
CZ372292A3 (en) 1993-12-15
EP0552631A1 (de) 1993-07-28
GR3025179T3 (en) 1998-02-27
MX9300136A (es) 1993-07-01
US5334610A (en) 1994-08-02
EP0552631B1 (de) 1997-09-24
NZ245726A (en) 1996-01-26
MY108826A (en) 1996-11-30
TW232011B (enExample) 1994-10-11
AU3188893A (en) 1993-07-29
IL104444A (en) 1997-06-10
HUT63394A (en) 1993-08-30
HU9300181D0 (en) 1993-04-28
SK278548B6 (en) 1997-09-10
IL104444A0 (en) 1993-05-13
ES2107562T3 (es) 1997-12-01
CA2087650A1 (en) 1993-07-24
PL297491A1 (en) 1993-08-09
AU650807B2 (en) 1994-06-30
CN1075714A (zh) 1993-09-01
SK372292A3 (en) 1997-09-10
CZ282024B6 (cs) 1997-04-16
DE59307401D1 (de) 1997-10-30
ZA93477B (en) 1993-08-23
JPH05286942A (ja) 1993-11-02
KR930016401A (ko) 1993-08-26
DE4201709A1 (de) 1993-07-29
PL172005B1 (pl) 1997-07-31
ATE158576T1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
ZA942131B (en) Pyridothiadiazines processes for their preparation and the pharmaceutical compositions which contain them
TW248559B (enExample)
DK0411733T3 (da) 11-beta-aryl-gona-4,9-dien-3-oner
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
JPS6419066A (en) Dihydropyridineamides
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
TW232011B (enExample)
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
GR3017280T3 (en) Aminoalkylchromones, process for their preparation and compositions containing them.
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
ES8800666A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidropiridina